Clinical Trial Update: Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares imeglimin versus metformin monotherapy in newly diagnosed type 2 diabetes, focusing on mitochondrial redox modulation. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Imeglimin (imeglimin)
• metformin (metformin)

Snippet

Sponsor: Mansoura University | Conditions: Mitochondria, Metformin | Phase 4 | Status: NOT_YET_RECRUITING